| Literature DB >> 32631242 |
Yashar Goorakani1, Massih Sedigh Rahimabadi2,3, Azizallah Dehghan2, Maryam Kazemi2, Mahsa Rostami Chijan2,3, Mostafa Bijani2, Hadi Raeisi Shahraki4, Ali Davoodi1, Mojtaba Farjam5, Reza Homayounfar6,7.
Abstract
BACKGROUND: There is a positive association between raised resting heart rate (RHR), and all causes of mortality and shorter life expectancy. Several serum biomarkers and some anthropometric factors can affect the resting heart rate. This study aimed to investigate the determinants of resting heart rate in a large random sample of the Iranian population.Entities:
Keywords: Alpha-blockers; BMI; Resting heart rate
Mesh:
Substances:
Year: 2020 PMID: 32631242 PMCID: PMC7336436 DOI: 10.1186/s12872-020-01594-y
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Anthropometric and biological factors in males and females in Fasa PERSIAN (Prospective Epidemiological Research Study in IrAN) cohort study
| Variable | Male ( | Female ( | |||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| Heart Rate (bpm) | 71.40 | 10.13 | 76.59 | 10.46 | |
| Age (years) | 49.52 | 9.69 | 49.57 | 9.59 | 0.79 |
| Waist circumference (cm) | 89.52 | 11.18 | 96.14 | 11.49 | |
| Hip circumference (cm) | 97.54 | 7.67 | 101.25 | 9.41 | |
| Wrist circumference (cm) | 17.28 | 1.23 | 16.27 | 1.25 | |
| DBP (mm Hg) | 74.88 | 11.39 | 75.36 | 11.79 | |
| SBP (mm Hg) | 111.39 | 17.20 | 112.76 | 18.87 | |
| BMI | 24.20 | 4.41 | 26.86 | 4.81 | |
| ABSI | 0.08 | 0.00 | 0.09 | 0.01 | |
| BAI | 26.47 | 3.70 | 34.15 | 5.11 | |
| AVI | 16.35 | 4.12 | 18.79 | 4.47 | |
| Conicity index | 1.29 | 0.08 | 1.37 | 0.08 | |
| WHR | 0.92 | 0.06 | 0.95 | 0.06 | |
| WHtR | 0.53 | 0.07 | 0.62 | 0.07 | |
| WBC (10^3/μL) | 6.58 | 1.78 | 6.38 | 1.67 | |
| RBC (10^6/μL) | 5.19 | 0.56 | 4.78 | 0.50 | |
| HGB (g/dL) | 15.66 | 1.58 | 13.88 | 1.47 | |
| HCT (%) | 44.39 | 3.82 | 39.99 | 3.74 | |
| MCV (fL) | 86.17 | 7.49 | 84.18 | 7.61 | |
| MCH (pg) | 30.44 | 3.14 | 29.28 | 3.16 | |
| MCHC (10^3/μL) | 35.31 | 1.19 | 34.74 | 1.21 | |
| PLT (%) | 247.71 | 60.71 | 296.38 | 72.93 | |
| Glucose (mg/dL) | 90.19 | 24.25 | 94.56 | 32.98 | |
| BUN (mg/dL) | 13.74 | 3.94 | 12.29 | 3.85 | |
| Cr (mg/dL) | 1.06 | 0.18 | 0.92 | 0.18 | |
| TG (mg/dL) | 135.98 | 90.80 | 128.50 | 74.82 | |
| Cholesterol (mg/dL) | 178.82 | 37.90 | 190.39 | 39.44 | |
| SGOT (U/L) | 23.84 | 8.41 | 21.56 | 8.91 | |
| SGPT (U/L) | 26.09 | 16.52 | 21.29 | 12.02 | |
| ALP (U/L) | 211.06 | 65.62 | 208.30 | 75.65 | 0.052 |
| HDL (mg/dL) | 47.26 | 14.42 | 54.20 | 16.42 | |
| LDL (mg/dL) | 104.44 | 31.44 | 110.57 | 33.43 | |
| GGT (U/L) | 25.82 | 22.56 | 20.42 | 20.07 | |
DBP Diastolic blood pressure, SBP Systolic blood pressure, BMI Body mass index, ABSI A body shape index, BAI Abdominal volume index, AVI Body adiposity index, WHR Waist to hip ratio, WHtR Waist to height ratio, WBC White blood cell, RBC Red blood cell, HGB Hemoglobin, HCT Hematocrit, MCV Mean cell volume, MCH Mean corpuscular hemoglobin, MCHC Mean corpuscular hemoglobin concentration, PLT Platelet, BUN Blood urea Nitrogen, Cr Creatinine, TG Triglyceride, SGOT Serum glutamic oxaloacetic transaminase, SGPT Serum glutamic pyruvic transaminase, ALP Alkaline phosphatase, HDL High-density lipoprotein, LDL Low-density lipoprotein, GGT Gamma glutamine transferase
Fig. 1The frequency of use of different drugs in Fasa PERSIAN (Prospective Epidemiological Research Study in IrAN) cohort population (n = 9975)
Fig. 2Multivariate Scasde quantile regression between resting heart rate and suspected determinants in Fasa PERSIAN (Prospective Epidemiological Research Study in IrAN) cohort
Results of SCAD linear regression to modeling resting heart rate in Fasa PERSIAN (Prospective Epidemiological Research Study in IrAN) cohort
| Variable | Model 1 | Variable | Model 2 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| β | Standard β | SE | β | Standard β | SE | ||||
| Sex (male is ref) | 4.88 | 0.21 | 0.33 | <0.001 | Sex (male is ref) | 4.62 | 0.22 | 0.211 | <0.001 |
| SBP | 0.08 | 0.13 | .006 | <0.001 | SBP | 0.11 | 0.19 | 0.006 | 0.032 |
| HDL.C | 0.06 | 0.10 | 0.026 | 0.137 | Beta1.blockers | −2.35 | −0.07 | 0.021 | 0.006 |
| WBC | 0.34 | 0.17 | .32 | .288 | Age | −0.05 | − 0.05 | − 0.03 | 0.012 |
| GLUC | 0.04 | 0.11 | 0.004 | <0.001 | BMI | 0.08 | 0.04 | 0.07 | 0.003 |
| Beta1.blockers | 1.12 | −0.06 | 0.002 | <0.001 | Opium | −1.89 | −0.04 | 0.28 | <0.001 |
| TG | 0.01 | 0.06 | 0.001 | <0.001 | Levothyroxine | −1.41 | −0.02 | 0.42 | <0.001 |
| SGPT | 0.006 | 0.009 | 0.007 | 0.39 | Alpha. blockers | 5.2 | 0.02 | 1.27 | <0.001 |
| DBP | 0.171 | 0.193 | 0.009 | .009 | TCA | 2.13 | 0.02 | 1.02 | <0.001 |
| Age | −.018 | −.016 | .011 | .111 | Metformin | 1.20 | 0.02 | 0.13 | 0.001 |
| SGOT | −.027 | − 024 | .12 | .028 | WC | 0.39 | 0.003 | 0.043 | 0.008 |
| BUN | −0.21 | −0.08 | .027 | <0.001 | SSRI | −1.00 | − 0.01 | − 0.91 | <0.001 |
| WC | 0.12 | 0.05f | 0.008 | <0.001 | WHR | 2.29 | 0.01 | 0.031 | <0.001 |
| Opium | −1.69 | −0.13 | 0.004 | <0.001 | Antihistamine | 1.55 | 0.01 | 0.178 | 0.003 |
| TCA | 1.94 | 0.02 | 1.12 | <0.001 | Beta2.agonist | 2.2 | 0.01 | 0.98 | .002 |
| Alpha. blockers | 4.87 | 0.02 | 1.32 | <0.001 | Diuretics | 0.64 | 0.01 | 0.24 | 0.001 |
| HGB | 0.09 | 0.01 | 0.02 | <0.001 | |||||
| Levothyroxine | −0.93 | −0.81 | − 0.71 | 0.471 | |||||
| Metformin | −11.78 | −10.36 | −3.41 | 0.291 | |||||
| SSRI | −1.15 | −0.01 | −.98 | 0.003 | |||||
| Diuretics | 0.87 | 0.005 | 0.73 | 0.004 | |||||
| LDL | −0.01 | −0.003 | −0.02 | 0.006 | |||||
| Beta2.agonist | 0.88 | 0.002 | 0.56 | 0.042 | |||||
| Antihistamine | 1.46 | 3.11 | 0.74 | 0.639 | |||||
| ABSI | −28.04 | −0.001 | −19.1 | 0.132 | |||||
DBP Diastolic blood pressure, SBP Systolic blood pressure, BMI Body mass index, ABSI A body shape index, WHR Waist to hip ratio, WBC White blood cell, RBC Red blood cell, HGB Hemoglobin, HCT Hematocrit, MCV Mean cell volume, MCH Mean corpuscular hemoglobin, MCHC Mean corpuscular hemoglobin concentration, PLT Platelet, BUN Blood urea Nitrogen, Cr Creatinine, TG Triglyceride, SGOT Serum glutamic oxaloacetic transaminase, SGPT Serum glutamic pyruvic transaminase, ALP Alkaline phosphatase, HDL High-density lipoprotein, LDL Low-density lipoprotein, GGT Gamma glutamine transferase
a Model 1, HR considered as dependent variable, and all of the other 41 factors (aforementioned in Table 1 and drugs) were considered as independent variables. The proposed model represents 25 variables as effective factors on resting heart rate
b Only comprised age, sex, BMI, waist circumference, WHR, SBP, and drugs because the excluded variables show a bidirectional confounding relationship with RHR